On September 30, Gelunhui | cvs health (CVS.US) rose by 2.2%, to $62.73. In terms of news, according to The Wall Street Journal, the hedge fund Glenview Capital Management, specializing in medical care, will meet with executives of cvs health on Monday to offer suggestions for improving operations. Currently, Glenview holds approximately 1% of cvs health's outstanding shares.
美股异动丨西维斯健康涨2.2% 对冲基金Glenview将与公司高管会面以推动改革
U.S. stocks unusual movement: cvs health rose 2.2%, Hedge fund Glenview will meet with company executives to promote reform.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.